Allergy-like nocebo events reported with COVID-19 vaccines: a case control study
The nocebo effect appears to differ by vaccine type and is more common in individuals with a history of allergy and lower perceived vaccine effectiveness. While further research is needed to validate these findings, this underscores the importance of clear, evidence-based communication to reduce nocebo responses.
Authors
- Anca Mirela Chiriac (ORCID: https://orcid.org/0000-0002-1558-1966)
- Virginie Brès (ORCID: https://orcid.org/0000-0001-7960-068X)
- Jean‐Luc Faillie (ORCID: https://orcid.org/0000-0003-0100-4073)
- Guillaume Broc (ORCID: https://orcid.org/0000-0002-8684-9325)
- Najah Ben Fadhel (ORCID: https://orcid.org/0000-0001-9558-0666)
- Raphaël Trouillet (ORCID: https://orcid.org/0000-0002-4133-7094)
Institutions
- Inserm (FR)
- University of Monastir (TN)
- Université de Montpellier (FR)
- Université Paul-Valéry Montpellier (FR)
- Centre Hospitalier Universitaire de Montpellier (FR)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1080/14740338.2025.2497397
- Primary Topic
- Pain Management and Placebo Effect
- Type
- article
- Field-Weighted Citation Impact
- 0.00